These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 404425)

  • 1. Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes.
    Omura S; Nakagawa A; Sakakibara H; Okekawa O; Brandsch R
    J Med Chem; 1977 May; 20(5):732-6. PubMed ID: 404425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of leucomycins and analogues on binding [14C ]erythromycin to Escherichia coli ribosomes.
    Pestka S; Nakagawa A; Omura S
    Antimicrob Agents Chemother; 1974 Nov; 6(5):606-12. PubMed ID: 15825314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic and lipophilic interactions of macrolides (leucomycin derivatives) with ribosomal receptor sites.
    Mager PP
    Acta Histochem; 1980; 66(1):40-3. PubMed ID: 6776777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of a 16-membered macrolide. Binding of rosaramicin to the Escherichia coli ribosome and its subunits.
    Siegrist S; Lagouardat J; Moreau N; LeGoffic F
    Eur J Biochem; 1981 Apr; 115(2):323-7. PubMed ID: 6786880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of [3H]tetrahydroleucomycin A3 to Escherichia coli ribosomes and the effect of 3"-O-acyl derivatives of leucomycins on the binding.
    Omura S; Tanaka H; Inokoshi J; Sakakibara H; Fujiwara T
    J Antibiot (Tokyo); 1982 Apr; 35(4):491-6. PubMed ID: 7047480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity relationships of O-acyl derivatives of leucomycin for antimicrobial and ribosome-binding activities.
    Tanaka H; Moriguchi I; Hirono S; Omura S
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2803-8. PubMed ID: 4085039
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel leucomycin analogues modified at the C-3 position. I. Epimerization and methylation of the 3-hydroxyl group.
    Furuuchi T; Kurihara K; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2003 Apr; 56(4):399-414. PubMed ID: 12817814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
    Omura S; Miyano K; Matsubara H; Nakagawa A
    J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of 3-O-acetyl-4"-O-isovaleryltylosin to ribosomes from a macrolide-resistant strain of Staphylococcus aureus.
    Tsuchiya M; Sawa T; Takeuchi T; Umezawa H; Okamoto R
    J Antibiot (Tokyo); 1982 Jun; 35(6):673-9. PubMed ID: 7118723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure activity relationships of spiramycins.
    Omura S; Sano H; Sunazuka T
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():1-11. PubMed ID: 3902764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
    Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
    J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of ribosomes from Streptomyces erythreus and Streptomyces griseus.
    Teraoka H; Tanaka K
    J Bacteriol; 1974 Oct; 120(1):316-21. PubMed ID: 4138441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered ribosomes in spiramycin-resistant mutants of Bacillus subtilis.
    Ahmed A
    Biochim Biophys Acta; 1968 Aug; 166(1):218-28. PubMed ID: 4972350
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of tylosin derivatives effective against macrolide-resistant strains: synthesis and structure-activity relationships.
    Tsuchiya M; Hamada M; Takeuchi T; Umezawa H; Yamamoto K; Tanaka H; Kiyoshima K; Mori S; Okamoto R
    J Antibiot (Tokyo); 1982 Jun; 35(6):661-72. PubMed ID: 7118722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosome-binding activities and antimicrobial activities of tylosin and its related compounds.
    Omura S; Inokoshi J; Matsubara H; Tanaka H
    J Antibiot (Tokyo); 1983 Dec; 36(12):1709-12. PubMed ID: 6662812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and structure-activity relationship studies of novel pleuromutilin derivatives having a piperazine ring.
    Luo J; Yang QE; Yang YY; Tang YZ; Liu YH
    Chem Biol Drug Des; 2016 Nov; 88(5):699-709. PubMed ID: 27273921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical modification of tylosin: synthesis of amino derivatives at C-20 position of tylosin and demycarosyltylosin.
    Matsubara H; Inokoshi J; Nakagawa A; Tanaka H; Omura S
    J Antibiot (Tokyo); 1983 Dec; 36(12):1713-21. PubMed ID: 6662813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of some classical hydrazones of ketones and 1,2-diketones as antileishmanial, antibacterial and antifungal agents.
    Al-Kahraman YM; Yasinzai M; Singh GS
    Arch Pharm Res; 2012 Jun; 35(6):1009-13. PubMed ID: 22870810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of ribosomal binding and antibacterial properties of tylosin-type antibiotics.
    Corcoran JW; Huber ML; Huber FM
    J Antibiot (Tokyo); 1977 Nov; 30(11):1012-4. PubMed ID: 412822
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemical modification of spiramycins. II. Synthesis and antimicrobial activity of 4'-deoxy derivatives of neospiramycin I and their 12-(Z)-isomers.
    Sano H; Inoue M; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):738-49. PubMed ID: 6469868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.